Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women (Replicate Study)

NCT02691494 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

378

Enrollment

INDUSTRY

Sponsor class

Conditions

Uterine Fibroids
Heavy Menstrual Bleeding

Interventions

DRUG: Elagolix
DRUG: Placebo for Estradiol/Norethindrone Acetate
DRUG: Estradiol/Norethindrone Acetate
DRUG: Placebo for Elagolix

Sponsor

AbbVie